Acadia Pharmaceuticals (United States)

313 papers and 7.9k indexed citations i.

About

In recent decades, authors affiliated with Acadia Pharmaceuticals (United States) have published 313 papers, which have received a total of 7.9k indexed citations. Scholars at this organization have produced 81 papers in Molecular Biology, 79 papers in Psychiatry and Mental health and 66 papers in Cellular and Molecular Neuroscience on the topics of Receptor Mechanisms and Signaling (55 papers), Parkinson's Disease Mechanisms and Treatments (53 papers) and Schizophrenia research and treatment (44 papers). Their work is cited by papers focused on Molecular Biology (3.1k citations), Cellular and Molecular Neuroscience (2.6k citations) and Psychiatry and Mental health (1.1k citations). Authors at Acadia Pharmaceuticals (United States) collaborate with scholars in United States, Sweden and United Kingdom and have published in prestigious journals including New England Journal of Medicine, The Lancet and Angewandte Chemie International Edition. Some of Acadia Pharmaceuticals (United States)'s most productive authors include Ethan S. Burstein, Tracy A. Spalding, Edward I. George, Hugh Chipman, Robert E. McCulloch, David M. Weiner, Mark R. Brann, Roger Olsson, Roger Mills and Uli Hacksell.

In The Last Decade

Fields of papers published by authors at Acadia Pharmaceuticals (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Acadia Pharmaceuticals (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Acadia Pharmaceuticals (United States) at the time of their publication.

Countries citing scholars working at Acadia Pharmaceuticals (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Acadia Pharmaceuticals (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Acadia Pharmaceuticals (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Acadia Pharmaceuticals (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at University of Reunion Island Breakdown of academic impact, for scholars at Dent Neurologic Institute Breakdown of academic impact, for scholars at Washington and Jefferson College Breakdown of academic impact, for scholars at AVEO Oncology (United States) Breakdown of academic impact, for scholars at BioReliance (United States) Breakdown of academic impact, for scholars at Baird Institute Breakdown of academic impact, for scholars at Laboratoire d'Ecogéochimie des Environnements Benthiques Breakdown of academic impact, for scholars at Chongqing Science and Technology Commission
Rankless by CCL
2025